A researcher is working on a nasal spray to protect against COVID-19. He thinks a similar tool could protect against the flu and colds as well.
Funding for digital health surged in 2021 amid the coronavirus pandemic, but it suffered a big downturn in 2022.
Artificial intelligence has the potential to make possible new therapeutics, drugs, and tests, Flagship Pioneering CEO Noubar Afeyan said.
Atai Life Sciences' ketamine-based therapy failed to help patients with depression in a mid-stage trial.
Retail pharmacies can start dispensing the abortion pill after an FDA ruling, expanding access to reproductive healthcare.
Pelé, a legendary Brazilian soccer player, died of colon cancer. These clinical trials are studying new treatments for the disease.
The current strain of cholera fueling an outbreak in Haiti is likely related to the strain that caused the 2010 outbreak, according to scientists.
Prenuvo offers full-body MRI scans to help find diseases early. Experts say you probably don't need one — and that it could do more harm than good.
NYU Langone gave VIPs, such as trustees and donors, preferential treatment while others waited, according to a report from The New York Times.
Flu season continues to thrash the US. The government is now allowing states to access the national stockpile of Tamiflu to cope.
Madrigal Pharmaceuticals reported positive results for its treatment for NASH. It hopes to file for FDA approval in 2023.
We asked investors to name the startups poised for success in a tough market, from young upstarts to companies on the brink of going public.
Some researchers are working on a strep-A vaccine, but it will be a long time before one is available.
A new study says that direct-to-consumer companies may not be educating patients about the risks of testosterone.
Pfizer and Valneva have said their vaccine produced immunity in phase 2 trials. If phase 3 pans out, they may have the first Lyme vaccine in 20 years.
An early study found that recipients of an experimental HIV vaccine showed immune system activity. It could be a cause for hope in the long-running effort to find a vaccine.
Laksh Aithani founded one of biotech's hottest startups. The first-time CEO shared how he jumped from college student to biotech exec.
The economic slowdown is making it harder for biotech founders to raise money. An investor says founders should be creative and aggressive when trying to raise more capital.
Vinod Kholsa said primary care and AI both had major roles to play in reducing healthcare costs. Here's how he thinks it could work.
These 16 biotech investors are all in their first decade of working in venture capital and bringing fresh perspectives to the world of biotech.